Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

nded, `H.R. 5804 - DHS Blue Campaign Enhancement Act', as amended under suspension of the rules Location: U.S. Capitol, Washington, DC; 11.00 AM * House Natural Resources Committee virtual legislative hearing — Virtual legislative hearing on the Environmental Justice for All Act, with testimony from Texas Southern University Pr

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

nded, 'H.R. 5804 - DHS Blue Campaign Enhancement Act', as amended under suspension of the rules Location: U.S. Capitol, Washington, DC; 11:00 AM • House Natural Resources Committee virtual legislative hearing - Virtual legislative hearing on the Environmental Justice for All Act, with testimony from Texas Southern University Pr

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

nded, 'H.R. 5804 - DHS Blue Campaign Enhancement Act', as amended under suspension of the rules Location: U.S. Capitol, Washington, DC; 11:00 AM • House Natural Resources Committee virtual legislative hearing - Virtual legislative hearing on the Environmental Justice for All Act, with testimony from Texas Southern University P

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

nded, 'H.R. 5804 - DHS Blue Campaign Enhancement Act', as amended under suspension of the rules Location: U.S. Capitol, Washington, DC; 11:00 AM • House Natural Resources Committee virtual legislative hearing - Virtual legislative hearing on the Environmental Justice for All Act, with testimony from Texas Southern University P